Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
A number of suspect higher volume trades appear to exist apr 24 two trade days before the big announcement. Smell of insider info trading? About 100k shares total bought throughout the day in smaller blocks, uncharacteristic blocks for this stock at that time.
this is never going to happen sell it
correction "cat this quarter" not cat this month
Wow, I cant believe this got by EVERYONE
Doesn't ANYONE wonder WHY people are even BUYING a stock targeted at only 1.28 in 12 months for over 2 dollars ?
HELLO HUGE MISTAKE HERE
On April 24 the stock is trading at 40 cents and the 12 month is downgraded to 1.34
On April 28 the 8 1 split is announce and the stock is reduced from 80 to 10 million shares.
It opens close to 3 dollars and immediately starts dropping for no reason to almost 2 dollars.
Because people SEE THE 12 MONTH SET at 1.34 and dump it. They think THEY are getting over on BUYERS.
LOOK....
says 80 million shares out and target 1.28, yep, on the 24th, but not now, only 10 million out, and that 1.24 is eight times that.
http://finviz.com/quote.ashx?t=anth
4 days before split, that no one knows about, downgrade 12 month to 1.34
http://standardoracle.com/2017/04/24/jefferies-downgrade-its-coverage-for-anthera-pharmaceuticals-inc-anth/
then split is announced days later
http://secfilings.nasdaq.com/filingFrameset.asp?FilingID=12024803&RcvdDate=4/28/2017&CoName=ANTHERA%20PHARMACEUTICALS%20INC&FormType=8-K&View=html
Does no one wonder why anyone would even BUY a stock with a 12 month of less than 2 dollars for over 2 dollars ?
Anyhow, I have been buying it
Oh, they also have a catalyst this month, clinical trial data release :)
past performance does not play on this
1- trump is the president
2- bpmx, even though its up, is underperforming the market by 30%
3- the time from proposed drug to actual drug is 2/3 over, closer to realization.
4- pp of the drug is 100% and looks GREEN as hell
5- not a new drug, existing drug new application method, using 90% less drug thats NOT ingested
6- taking on a 450 million a year market that it can dominate
yeah,,,experts, listen to them and their charts, will cost you tons of money.
important positive news
https://clinicaltrials.gov/archive/NCT02946788/2017_03_27/changes
Food for thought
BPMX has used this sentence three times in the past in filings and releases.
If everything goes well, we estimate BPX01 will be approved by the FDA in calendar 2019. Peak sales of BPX01 should be around $450 million.
topline phase 2b data could be released as soon as monday. confirmation of the 5 million offering closure may not come until after hours friday. may be zero trading hours between the two.
This is how they fund their operations, they have done it three times in 2016. 16 million. They will have to do another 20 million for phase 3 on bpx 01. The 5 million they just did is only general operating costs for 3 or 4 months. Expect another 15 to 20 million around august sept assuming phase 2b leads to phase 3.
There is zero reason to be involved with this stock, I just read their filings, I seriously have more money spent on cat food than they have in cash. I am not kidding.
Well some of them may have more money now.....
Forget charts and experts
Death cross, golden cross, double cross, out the window on this one.
Stock is rising on speculation that the soon to be released phase 3 result for acne drug BPX-01 will be great...we will see.
Compare to ....
Proactiv has been a spectacular success for its makers, two dermatologists in the San Francisco Area, and the company that markets it, Guthy-Renker. Its annual sales, $1.5 billion, tower over the rest of the acne treatment industry.
So what’s in this blockbuster drug? After all, the basic “Proactiv System” will cost you $19.95 (though it’s “a $72 value”). The short answer is not much. Make a few clicks around Proactiv’s website and you’ll find out the active compound is benzoyl peroxide. That’s the same stuff in Stridex, Clearasil and just about every nonprescription acne medication available in drugstore aisles across America. A tube of the same compound costs $5.25 at my local pharmacy.
They made 1.5 billion with benzoyl peroxide..that already existed in over the counter products, they just used justin beiber to market it. genius.
BPMX has BPX-01 coming out of phase 3. It is a TOPICAL antibio that BYPASSES ingestion.
If it worked,,, and goes on to pass later trials and get approved, the market will be well over proactives 1.5 billion.
That's why charts dont matter on this one,,,the phase 3 results DO.
And that's why its up 14% just today :)
We expect phase 3 data any day now
GO GO GO
I posted earlier in error...
"Their phase 2a phase 2b and newly completed but unreleased phase 3 testing on BPX-01 is all I am following."
I was thinking of my breast drug stock trials :)
BPMX has completed phase 2b and we are awaiting those results,,, any minute :)
Then phase 3 :)
Twitter: ARYC REVENUE
From October 4, 2016 to April 12, 2017
A period of 128 business days.
--------------------------------------------
ARYC Twitter Gross Revenue Disclosures
-------------
$717,600 in hardware sales ($5,605.25 per day)
(avg hardware sale price $21,105.88)
Total of 34 sales of services reported over the 128 business days
-------------
$927,500 from sales of services ($7,246.09 per day)
(avg hardware sale price $38,645.83)
Total of 24 sales of services reported over the 128 business days
-------------
$92,600 from a "life sciences" sale
(one sale but broken out per day it is $723.44 over the 128 day period)
-------------
Total average daily gross from sales and service over the 128 day period
Per their twitter posting...
$13,574.78
Times 251 business days for yearly gross revenue
$3,407,269.78 (thats gross, before operating cost, costs of sales salaries debts etc.)
"For the people struggling with moderate Acne, especially the youngsters, best believe Drs will prescribe Topical minocycline before any oral antibiotic is given. No doubt."
EXACTLY...that's why I bought in. If it comes out of testing and goes to market, it could be a major player.
accutane..1980...i was one of the test subjects nih bethesda maryland.
it reversed it 100% and i only took it 10 days, quit way early due to the side effects.
fyi the phase 3 data is not expected to be released..from what i understand as of yesterday, until q3 2017.
Not buying it...literally.
Ok lets says this company has 30k a day in sales times 251 work days 7.5 million gross a year. Lets also pretend they get the product for free and have no operating costs.
Divide that 7.5 million up into shares of stock and see what you get.
I would also point out that in the ONLY financials I can find they PAID more money to sell than they got back. COST OF SALES exceeded sales. That only works in Venezuela.
https://www.hotstocked.com/article/90461/arrayit-corp-otcmkts-aryc-bounces-thanks-to.html
https://www.genomeweb.com/microarrays-multiplexing/arrayit-legal-dispute-investor-continues-despite-settlement-disclosure
http://www.fiercebiotech.com/biotech/sec-hits-out-at-paid-for-bio-analysts-ceos-and-firms-charges-27
Disclosure: I own a lot of this stock...I keep selling and buying it and accruing more for of it. My belief is that this stock is going to move and when it does it's going to do so hard and fast.
I don't read any of the financials on this one or review any of the fancy sheets and graphs on earnings etc.
Their phase 2a phase 2b and newly completed but unreleased phase 3 testing on BPX-01 is all I am following.
The reason I got into this stock was because I understand the fundamentals of what they are doing and what the product is based on. Its not so much a new drug as a new method of application (topical versus ingested) so its built on a drug that has lots of testing and is in use today. That could result in a very fast track if phase 3 worked out.
The market for the product never goes away as long as new customers are being born and those that need the relief the product may provide, if approved, will want that relief.
The market they are going after is an existing 3 billion a year market in the usa alone, they ultimately could capture a significant portion of that market.
I have reason to believe phase 3 worked out great based on "tea leaves" consisting of publicly available information some of which is provided by a federal government website as well as publicly observable activities directly related to bpx-01 phase 3 activities. BUT I COULD BE 100% WRONG.
I would advise that you look at all you can find on bpmx and bpx-01 and see how it looks to you.
Twitter is not financials.
I too saw all the twitter posts
Meaningless
Even if true they dont tell the story
For example, here is what was posted once before by them
Gross margin
2014 2,575,058 << good
2013 1,124,787
Selling, general and administrative
2014 5,885,930 << wtf
2013 1,765,971
Income (loss) from operations
2014 (3,622,518) << there went the margin
2013 (779,931)
So you can post on a twitter a billion in sales, but if operations and salaries eat it all up... meaningless
Not 0.0001 but 0.001 par value.
I am looking at some filing where they file a signed certification to increase the shares to 960 million total, and above that is an unsigned certification form yet the vote totals are entered, and that states they have a whopping 2 billion 480 million shares.
LOL
so at 960 million and 0.001 par they are worth 960 thousand dollars
and at 2 billion 480 million shares 2.48 million dollars
So no idea what they did here, is it 960 million or 2 billion 480 million shares of common stock they authorized ?
Cash
2014 $22,587 << I have that in my gun safe
2013 $290,659
2014 Common stock, $0.001 par value, voting, 480,000,000 shares authorized, 54,691,581 and 38,139,616 issued and outstanding
Gross margin
2014 2,575,058 << good
2013 1,124,787
Selling, general and administrative
2014 5,885,930 << wtf
2013 1,765,971
Income (loss) from operations
2014 (3,622,518) << there went the margin
2013 (779,931)
So....where are the financials for 2016 ?
GOFUNDME NOT ARYC :)
Seriously... are you all kidding with this company ?
I just wasted three hours of my life pouring over the filings for this company,,,and their self serving twitter, which is laughable in its execution.
Where are the financials for 2016 ,,, or 2015, I see a filing for 2015 with no numbers.
I see a filing where the company says the stocks is worth 0.0001 which I agree with.
I see they had 9 employees and shrunk to 7 employees. The office will have to close so they can all head across the globe to attend all those multi million dollar events they have been invited to participate in.
The size of the office is the same as my house according to their 2014 filing.
They pay a 5% royalty to someone, maybe their dad ? That's off GROSS sales...sweet deal. It appears they OWE him that for at least two years,,, so he got stiffed too ?
Their revolving line of credit was increased from 750k to about a million ?
That is going to SEVERELY hamper the amount of sales they can achieve monthly.
That filing that their registered accountant agent left/resigned...that's a huge red flag for me. as are the missing financials. I can think of one good reason the financials aren't produced and the person is gone.
It will be interesting to see how this plays out.
Signing off from Washington D.C.
( I'll monitor this to see how wrong I have been in my assessment of the appearance of the facts,,, that I can find )